The Na+ CP type IXα inhibitors belong to a distinctive chemical class renowned for their significant influence on cellular sodium ion channels, particularly the Na+ CP type IXα isoform. This class of compounds primarily functions by selectively obstructing the activity of these specific sodium ion channels, which play a crucial role in regulating sodium influx across cell membranes. These inhibitors are characterized by their capacity to modulate the sodium ion gradient, which in turn has a far-reaching impact on various physiological processes. Structurally, Na+ CP type IXα inhibitors often possess intricate arrangements of functional groups, allowing them to interact with the target channel with a high degree of specificity. This enables the inhibitors to obstruct sodium ion influx while having minimal interference with other cellular processes.
The precise binding mechanism of these inhibitors to the sodium channel is often attributed to their ability to interact with key residues within the channel's pore region. Through these interactions, these inhibitors are able to alter the conformation of the channel, thereby hampering the passage of sodium ions. This intricate molecular interaction underlines the high selectivity exhibited by Na+ CP type IXα inhibitors. The distinctive pharmacophore of Na+ CP type IXα inhibitors is responsible for their remarkable potency and selectivity. This class of inhibitors offers researchers a valuable tool to probe the functional role of the Na+ CP type IXα isoform in cellular physiology. By perturbing sodium ion transport, these inhibitors enable the exploration of intricate signaling cascades and cellular responses that rely on sodium ion gradients. Moreover, the continuous advancement in our understanding of the structural determinants governing the interaction between these inhibitors and their target channel has paved the way for the rational design of novel compounds with improved efficacy and selectivity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rivaroxaban | 366789-02-8 | sc-208311 | 2 mg | $155.00 | 18 | |
Rivaroxaban is a anticoagulant that inhibits factor Xa in the coagulation cascade, blocking the generation of thrombin and preventing blood clot formation. | ||||||
Apixaban | 503612-47-3 | sc-364406 sc-364406A | 10 mg 50 mg | $235.00 $622.00 | 2 | |
Apixaban is another factor Xa inhibitor that prevents clot formation by interfering with the activity of factor Xa, a crucial enzyme in the coagulation pathway. | ||||||
Edoxaban | 480449-70-5 | sc-483508 | 25 mg | $522.00 | ||
Edoxaban is a directl anticoagulant that targets and inhibits factor Xa, reducing the risk of thrombus formation and subsequent clot-related complications. | ||||||
Betrixaban | 330942-05-7 | sc-503540 | 100 mg | $7500.00 | ||
Betrixaban is a factor Xa inhibitor that prevents the formation of blood clots by selectively blocking the activity of factor Xa, a key player in the coagulation cascade. | ||||||